eurofarma, sociedad anonima
- Company typePrivate
- Founded1972
- HeadquartersItapevi, Brazil
- Headcount5,001–10,000
- GTM typeB2C
- OfferingHardware or Manufacturing
eurofarma, sociedad anonima firmographics
Firmographics- Name
- eurofarma, sociedad anonima
- Legal name
- Eurofarma Laboratórios S.A.
- Website
- https://eurofarma.com.gt
- Company type
- Private
- Founded year
- 1972
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
eurofarma, sociedad anonima industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Global Supply Chain, Procurement & Market-Shaping Partnerships (Medicines/Diagnostics/Vaccines) (HLAJAOAK)
- akta.pro secondary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where eurofarma, sociedad anonima is headquartered
LocationHeadquarters
- HQ city
- Itapevi
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
eurofarma, sociedad anonima business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Pharmaceutical Products: Eurofarma manufactures and commercializes pharmaceutical products including prescription medications, OTC products, and health-related products through pharmacies and healthcare providers across Latin America.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
eurofarma, sociedad anonima product offering
Product offeringCore offering
Eurofarma manufactures and commercializes a broad portfolio of pharmaceutical products including prescription medications, generic medicines, over-the-counter products, hospital medicines, and oncology therapeutics across more than 20 countries in Latin America and Africa. The company distributes through pharmacy networks, healthcare professional channels, and B2B partner networks, and operates supporting platforms including the +Verde sustainable packaging seal initiative, EuroCuida patient discount programs, and EurON Pro healthcare professional platform. The group also encompasses veterinary pharmaceuticals (Pearson Saúde Animal), consumer health (Momenta), and a human milk bank (Lactare).
Product overview
Eurofarma is a pharmaceutical company with over 50 years of history operating in more than 20 countries. The company offers a portfolio of pharmaceutical products across various therapeutic categories, supplemented by patient support programs like EuroCuida, customer service through its CAE center, and sustainability-focused products marked with the +Verde eco-seal. Additional services include a restricted access portal for healthcare professionals, pharmacovigilance reporting, health education content, and an indicator center for financial and ESG performance transparency.
Differentiator
Problem solved
Functional benefit
Brands
- Momenta: Pharmaceutical brand focused on consumer health products including wellness and lifestyle medications.
- EuroCuida
- Pearson Saúde Animal
- Instituto Eurofarma
- Lactare
- EurON Pro
- +Verde (+Green)
Products and services
- Pharmaceutical Product Portfolio
- +Verde (Eco-Friendly Pharmaceutical Line)
- EuroCuida Semaglutide Discount Program
Quantifiable outcome
- 49.5 million+ medications with +Verde seal sold since 2018, reducing 1.56 tons of carbon equivalent
Companies that use eurofarma, sociedad anonima
Customer profileSegments3 records
Ideal customer profiles3 records
eurofarma, sociedad anonima technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
eurofarma, sociedad anonima partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- ANVISA (Brazilian Health Regulatory Agency)coreANVISA validated Eurofarma's unique domestic decontamination methodology for blister packaging - a globally unprecedented process developed by Eurofarma. This regulatory validation enables the +Verde seal certification.
- Universidade São CamilominorCollaboration with Universidade São Camilo for clinical care support in the lactation process, demonstrating commitment to maternal and child health programs.
- Stock Car Racing TeamminorEurofarma maintains a proprietary Stock Car racing team for 20 years as part of sports sponsorship and brand visibility initiatives.
Scale indicators10 records
eurofarma, sociedad anonima competitors and assessment
Company assessmentDirect peers
- EMS Pharma: Brazil's largest pharmaceutical company by units sold, with a similar generics-anchored portfolio across prescription, OTC, and hospital segments in the Brazilian market. EMS competes head-to-head with Eurofarma in domestic tenders, pharmacy distribution, and therapeutic categories, making it the closest direct peer.
- Hypera Pharma: Major Brazilian pharmaceutical manufacturer with leading positions in OTC, generics, and consumer health, plus a strong branded portfolio. Hypera competes with Eurofarma across retail pharmacy channels and has overlapping therapeutic coverage in Brazil and select LatAm markets.
- Aché Laboratórios: Brazilian pharmaceutical company with branded prescription, generic, and OTC products plus an oncology franchise. Aché's therapeutic breadth, oncology focus, and domestic manufacturing footprint make it a direct comparable in the Brazilian prescription and specialty pharma market.
- Biolab Sanus Farmacêutica: Mid-to-large Brazilian pharmaceutical company with a prescription and hospital-focused portfolio including cardiovascular, women's health, and specialty therapeutics. Biolab's hospital channel presence and branded prescription approach overlap with Eurofarma's hospital and oncology segments.
Emerging players
- Aurobindo Pharma: Indian generic manufacturer with a substantial emerging-markets commercial footprint including Brazil and other LatAm countries. Aurobindo's cost advantage in API and finished generics makes it both a supply-side competitor and a source of pricing pressure on Eurofarma's generics portfolio across the region.
- Aspen Pharmacare: South African pharmaceutical company operating across Africa and select emerging markets with branded generics and specialty pharma franchises. Aspen's emerging-market-focused commercial model, regulatory infrastructure across multiple African jurisdictions, and therapeutic breadth parallel Eurofarma's LatAm/Africa multi-country playbook.
- Torrent Pharmaceuticals: Indian pharmaceutical manufacturer with a branded generics focus and growing international presence in Brazil, Mexico, and other LatAm markets. Torrent's emerging-market expansion and therapeutic breadth position it as an international comparable to Eurofarma's growth trajectory.
Broad incumbents
- Eurofarma's Medley/Sanofi (sanofi-aventis Brazil): Global pharma major with a Brazilian generics franchise (historically known as Medley) plus branded specialty products. Sanofi competes with Eurofarma across generics and branded segments in Brazil and other LatAm markets while bringing global scale advantages.
- Bayer Pharmaceuticals: Global pharmaceutical and consumer health company with established LatAm operations across prescription, consumer health, and animal health. Bayer's animal health overlap with Eurofarma's Pearson Saúde Animal subsidiary and its consumer health portfolio create comparable adjacencies.
- Zoetis: Global animal health leader spun off from Pfizer, with significant LatAm veterinary pharmaceutical presence. Zoetis serves as the global benchmark for Eurofarma's Pearson Saúde Animal veterinary subsidiary in terms of therapeutic breadth, market position, and margin profile.
Market position
Strengths5 records
Weaknesses5 records
Key risks6 records
Key highlights7 records
Customer concentration
eurofarma, sociedad anonima social profiles
Digital presenceeurofarma, sociedad anonima compliance and trust
Trust signalCompliance4 records
eurofarma, sociedad anonima financial estimates
Financial estimateRevenue estimate
Valuation estimate
eurofarma, sociedad anonima leadership team
Management profileNumber of profiles
eurofarma, sociedad anonima subsidiaries and ownership
Company hierarchySubsidiaries5 records
eurofarma, sociedad anonima funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
eurofarma, sociedad anonima M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about eurofarma, sociedad anonima
What does eurofarma, sociedad anonima do?
Eurofarma manufactures and commercializes a broad portfolio of pharmaceutical products including prescription medications, generic medicines, over-the-counter products, hospital medicines, and oncology therapeutics across more than 20 countries in Latin America and Africa. The company distributes through pharmacy networks, healthcare professional channels, and B2B partner networks, and operates supporting platforms including the +Verde sustainable packaging seal initiative, EuroCuida patient discount programs, and EurON Pro healthcare professional platform. The group also encompasses veterinary pharmaceuticals (Pearson Saúde Animal), consumer health (Momenta), and a human milk bank (Lactare).
Is eurofarma, sociedad anonima a public or private company?
eurofarma, sociedad anonima is a private company. It is classified as unknown and is currently operating.
When was eurofarma, sociedad anonima founded?
eurofarma, sociedad anonima was founded in 1972. It employs 5,001 to 10,000 people.
Where is eurofarma, sociedad anonima based?
eurofarma, sociedad anonima is headquartered in Itapevi, Brazil, in the Latin America region.
How does eurofarma, sociedad anonima make money?
One revenue line is on record: pharmaceutical Products.
Who are eurofarma, sociedad anonima's main competitors?
Direct peers on record are EMS Pharma, Hypera Pharma, Aché Laboratórios and Biolab Sanus Farmacêutica. Emerging players are Aurobindo Pharma, Aspen Pharmacare and Torrent Pharmaceuticals. Broad incumbents are Eurofarma's Medley/Sanofi (sanofi-aventis Brazil), Bayer Pharmaceuticals and Zoetis.
Does eurofarma, sociedad anonima have an API?
No public API is recorded for eurofarma, sociedad anonima.
What industry is eurofarma, sociedad anonima in?
eurofarma, sociedad anonima's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAJAOAK, Global Supply Chain, Procurement & Market-Shaping Partnerships (Medicines/Diagnostics/Vaccines), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 325412 and its SIC code is 2834.